Pathogenesis and Antimicrobial Resistance of Enterobacter Infection

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 409

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Affairs, Danaher Corporation/Cepheid China, Shanghai, China
Interests: molecular;clinical microbiology

E-Mail Website
Guest Editor Assistant
Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA
Interests: molecular microbiology; extrapulmonary tuberculosis; non-tuberculous mycobacteria

Special Issue Information

Dear Colleagues,

Enterobacter species is a facultative Gram-negative fermenter belonging to the Enterobacterales family and found ubiquitously in natural environments. Despite being a commensal member of the human and animals gastrointestinal tract (GIT) and respiratory tract, Enterobacter is considered an opportunistic pathogen. They are also frequently encountered in nosocomial settings, causing septicemia, respiratory, and wound infections. Carbapenems are the main drugs for the treatment of multidrug-resistant Enterobacter infections, but the rise of carbapenem resistance in Enterobacter species, primarily caused by the acquisition of carbapenemase-encoding genes, has significantly compromised the choice of clinical antimicrobial treatment. With an alarming crisis of carbapenem-resistant enterobacterales (CREs) worldwide, Enterobacter species contribute to rising CRE cases following E. coli and Klebsiella pnuemoniae. While some species display plasmid-mediated acquired resistance, most Enterobacter resistance is caused by the chromosomal AmpC beta-lactamase activity. This Special Issue describes the classification of clinically significant Enterobacter species and the pathogenic mechanisms contributing to its virulence and antimicrobial resistance. 

Prof. Dr. Yiwei Tang
Guest Editor

Dr. Phyu M. Thwe
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Enterobacter species
  • E. coli
  • Klebsiella pnuemoniae
  • carbapenem-resistant enterobacterales
  • pathogenesis
  • antibiotic resistance

Published Papers

This special issue is now open for submission.
Back to TopTop